Quick Answer
PALVELLA THERAPEUTICS, INC. reported Net Income Loss of -$41.72 million for the year ending 2025.
- PALVELLA THERAPEUTICS, INC. showed a decrease of -139.3% in Net Income Loss from 2024 to 2025.
- This data is from PALVELLA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2013 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2013 to 2025), PALVELLA THERAPEUTICS, INC.'s Net Income Loss has declined by 15,224,352.6%.
- Historical annual values: Fiscal year 2025: -$41.72 million | Fiscal year 2024: -$17.43 million | Fiscal year 2023: $18.69 million | Fiscal year 2022: -$33.28 million | Fiscal year 2021: -$45.74 million | Fiscal year 2020: -$37.23 million | Fiscal year 2019: -$25.47 million | Fiscal year 2018: -$26.75 million | Fiscal year 2017: -$17.65 million | Fiscal year 2016: -$22.80 million | Fiscal year 2015: -$14.06 million | Fiscal year 2014: -$9.85 million | Fiscal year 2014: -$15.7 thousand | Fiscal year 2013: $66.2 thousand | Fiscal year 2013: -$274.00.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: